Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Harrow Health ( (HROW) ) is now available.
Harrow Health said it has furnished a new corporate presentation for use by management at investor conferences and in meetings with investors. The materials were provided as part of a Form 8-K filing but are classified as furnished rather than filed, limiting their exposure to certain liabilities under U.S. securities laws.
By designating the presentation as furnished, the company aims to communicate updated information to the market while managing its regulatory risk profile. The move underscores Harrow Health’s ongoing investor-relations efforts without formally incorporating the content into its other securities law filings.
The most recent analyst rating on (HROW) stock is a Hold with a $35.00 price target. To see the full list of analyst forecasts on Harrow Health stock, see the HROW Stock Forecast page.
Spark’s Take on HROW Stock
According to Spark, TipRanks’ AI Analyst, HROW is a Neutral.
The score is held back primarily by leveraged financials, ongoing net losses, and historically weak/volatile cash conversion, alongside a bearish technical trend (below major moving averages with negative MACD). These are partially offset by a positive earnings outlook with specific 2026 revenue/adjusted EBITDA guidance and continued product-driven growth expectations.
To see Spark’s full report on HROW stock, click here.
More about Harrow Health
Average Trading Volume: 708,905
Technical Sentiment Signal: Hold
Current Market Cap: $1.31B
For detailed information about HROW stock, go to TipRanks’ Stock Analysis page.